Home > Insider Trading > Filing (0001578563-24-000182)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1665988	Bioventus Inc.	BVS	Surgical & Medical Instruments & Apparatus (3841)	810980861

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1914936	Leonard Mark Singleton	4721 Emperor Boulevard, Suite 100 Durham NC 27703	Svp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2024-03-21	18,625	$0.00	31,206	No	4	M	Direct
Class A Common Stock	Disposition	2024-03-22	5,541	$5.39	25,665	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Disposition	2024-03-21	18,625	$0.00	18,625	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,250			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2024 pursuant to a standing 10b5-1 instruction.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.36 to $5.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023.